Unknown

Dataset Information

0

Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study.


ABSTRACT:

Background

Since the first appearance of SARS-CoV-2 in China in December 2019, the world witnessed the emergence of the SARS-CoV-2 outbreak. Due to the high transmissibility rate of the virus, there is an urgent need to design and develop vaccines against SARS-CoV-2 to prevent more cases affected by the virus.

Objective

A computational approach is proposed for vaccine design against the SARS-CoV-2 spike (S) protein, as the key target for neutralizing antibodies, and envelope (E) protein, which contains a conserved sequence feature.

Methods

We used previously reported epitopes of S protein detected experimentally and further identified a collection of predicted B-cell and major histocompatibility (MHC) class II-restricted T-cell epitopes derived from E proteins with an identical match to SARS-CoV-2 E protein.

Results

The in silico design of our candidate vaccine against the S and E proteins of SARS-CoV-2 demonstrated a high affinity to MHC class II molecules and effective results in immune response simulations.

Conclusions

Based on the results of this study, the multiepitope vaccine designed against the S and E proteins of SARS-CoV-2 may be considered as a new, safe, and efficient approach to combatting the COVID-19 pandemic.

SUBMITTER: Ghafouri F 

PROVIDER: S-EPMC9302570 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8450176 | biostudies-literature
| S-EPMC7755200 | biostudies-literature
| S-EPMC8009247 | biostudies-literature
| S-EPMC7910514 | biostudies-literature
| S-EPMC7228377 | biostudies-literature
| S-EPMC7492789 | biostudies-literature
| S-EPMC8027208 | biostudies-literature
| S-EPMC7441805 | biostudies-literature
| S-EPMC7319648 | biostudies-literature
| S-EPMC7362859 | biostudies-literature